Nexeo Solutions to Be Commercial Source For The Mackstat® And Paragon® Preservatives
Oct 18, 2017 11:01 am UTC| Business
THE WOODLANDS, Texas, Oct. 18, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) announced they will be the commercial source for Mackstat® and Paragon® Preservatives product line globally. This decision comes as a result of...
Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017
Oct 18, 2017 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., Oct. 18, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
Oct 18, 2017 11:01 am UTC| Business
SAN FRANCISCO, Oct. 18, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, and its subsidiary FibroGen China Medical Technology Development Co., Ltd. (FibroGen China), today announced that...
Oct 18, 2017 11:01 am UTC| Business
VICTORIA, British Columbia, Oct. 18, 2017 -- Emerald Health Therapeutics Inc. (“EHT”) (TSXV:EMH) (OTCQX:EMHTF), through Emerald Health Botanicals Inc. ("Emerald"), its wholly owned subsidiary and a Licensed Producer...
Financial Gravity Tax Adds New Distribution Channel; Significant Impact on Revenues
Oct 18, 2017 11:01 am UTC| Business
ALLEN, Texas, Oct. 18, 2017 -- Financial Gravity Tax, Inc., a subsidiary of Financial Gravity Companies, Inc. (OTCQB:FGCO), announced the successful launch of a new Independent Agent distribution channel and is now...
Oct 18, 2017 11:01 am UTC| Business
FARMINGDALE, N.Y., Oct. 18, 2017 -- Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it will report financial...
Oct 18, 2017 11:00 am UTC| Business
WATERTOWN, Mass., Oct. 18, 2017 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye diseases, will report results for its first...